According to the IMS Health, a company that tracks prescription drug sales, the number of Accutane prescriptions in the initial half of 2006 decreased by 46 percent compared with the same period in 2005, and prescriptions for the leading generic version fell by 16 percent in the same time period. Related StoriesHSS experts help identify lupus patients at increased threat of issue pregnanciesComputerised cognitive behavioural therapy apt to be ineffective in major depression treatmentResilience-based programs might help LGBT youths cope with detrimental stressorsiPledge risk turning into something of a referendum on FDA’s ability to manage the risks and great things about powerful medications, the Journal reviews.There is currently no remedy for HS and there are no authorized medications for the treatment of the disease. ‘The clinical indicators of HS include nodules or abscesses. These can cause severe discomfort and foul-smelling discharge which can be upsetting for sufferers,’ said Alexa Kimball, M.D., M.P.H., PIONEER I Research Investigator, Medical Director at Massachusetts General Physicians Organization and Professor of Dermatology at Harvard Medical School. ‘Results of the study expand on previous function demonstrating that adalimumab can reduce the nodules and abscesses in patients with moderate-to-severe HS.’ Related StoriesACR releases 2015 Guideline for Treatment of Rheumatoid ArthritisMD Anderson research reveals why chemotherapy drugs not effective for many pancreatic tumor patientsSausages With Antioxidants From Berries To Prevent CancerStudy Results Outcomes from the PIONEER I research show that moderate-to-serious HS sufferers treated with HUMIRA 40 mg weekly achieved a significantly better response versus those on placebo at week 12 .